170 related articles for article (PubMed ID: 16201312)
1. Expression of natural antimicrobial peptide beta-defensin-2 and Langerhans cell accumulation in epidermis from human non-healing leg ulcers.
Galkowska H; Olszewski WL; Wojewodzka U
Folia Histochem Cytobiol; 2005; 43(3):133-6. PubMed ID: 16201312
[TBL] [Abstract][Full Text] [Related]
2. Expression of apoptosis- and cell cycle-related proteins in epidermis of venous leg and diabetic foot ulcers.
Galkowska H; Olszewsk WL; Wojewodzka U; Mijal J; Filipiuk E
Surgery; 2003 Aug; 134(2):213-20. PubMed ID: 12947320
[TBL] [Abstract][Full Text] [Related]
3. Keratinocyte and dermal vascular endothelial cell capacities remain unimpaired in the margin of chronic venous ulcer.
Galkowska H; Olszewski WL; Wojewodzka U
Arch Dermatol Res; 2005 Jan; 296(7):286-95. PubMed ID: 15565301
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.
Cianfarani F; Tommasi R; Failla CM; Viviano MT; Annessi G; Papi M; Zambruno G; Odorisio T
Br J Dermatol; 2006 Jan; 154(1):34-41. PubMed ID: 16403091
[TBL] [Abstract][Full Text] [Related]
5. Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers.
Galkowska H; Wojewodzka U; Olszewski WL
Wound Repair Regen; 2006; 14(5):558-65. PubMed ID: 17014667
[TBL] [Abstract][Full Text] [Related]
6. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers.
Cowin AJ; Hatzirodos N; Holding CA; Dunaiski V; Harries RH; Rayner TE; Fitridge R; Cooter RD; Schultz GS; Belford DA
J Invest Dermatol; 2001 Nov; 117(5):1282-9. PubMed ID: 11710945
[TBL] [Abstract][Full Text] [Related]
7. Increased number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with healing outcome.
Stojadinovic O; Yin N; Lehmann J; Pastar I; Kirsner RS; Tomic-Canic M
Immunol Res; 2013 Dec; 57(1-3):222-8. PubMed ID: 24277309
[TBL] [Abstract][Full Text] [Related]
8. Low recruitment of immune cells with increased expression of endothelial adhesion molecules in margins of the chronic diabetic foot ulcers.
Galkowska H; Wojewodzka U; Olszewski WL
Wound Repair Regen; 2005; 13(3):248-54. PubMed ID: 15953043
[TBL] [Abstract][Full Text] [Related]
9. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.
Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS
Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691
[TBL] [Abstract][Full Text] [Related]
10. Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers.
Blakytny R; Jude EB; Martin Gibson J; Boulton AJ; Ferguson MW
J Pathol; 2000 Apr; 190(5):589-94. PubMed ID: 10727985
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers.
Jude EB; Blakytny R; Bulmer J; Boulton AJ; Ferguson MW
Diabet Med; 2002 Jun; 19(6):440-7. PubMed ID: 12060054
[TBL] [Abstract][Full Text] [Related]
12. Human beta-defensin-2 expression is increased in chronic wounds.
Butmarc J; Yufit T; Carson P; Falanga V
Wound Repair Regen; 2004; 12(4):439-43. PubMed ID: 15260809
[TBL] [Abstract][Full Text] [Related]
13. Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects.
Smith CH; Allen MH; Groves RW; Barker JN
Br J Dermatol; 1998 Aug; 139(2):239-46. PubMed ID: 9767237
[TBL] [Abstract][Full Text] [Related]
14. Cytokines and growth factors in keratinocytes and sweat glands in chronic venous leg ulcers. An immunohistochemical study.
Tian YW; Stacey MC
Wound Repair Regen; 2003; 11(5):316-25. PubMed ID: 12950634
[TBL] [Abstract][Full Text] [Related]
15. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.
Kaplan G; Walsh G; Guido LS; Meyn P; Burkhardt RA; Abalos RM; Barker J; Frindt PA; Fajardo TT; Celona R
J Exp Med; 1992 Jun; 175(6):1717-28. PubMed ID: 1588289
[TBL] [Abstract][Full Text] [Related]
16. High-glucose environment reduces human β-defensin-2 expression in human keratinocytes: implications for poor diabetic wound healing.
Lan CC; Wu CS; Huang SM; Kuo HY; Wu IH; Liang CW; Chen GS
Br J Dermatol; 2012 Jun; 166(6):1221-9. PubMed ID: 22283836
[TBL] [Abstract][Full Text] [Related]
17. Cultured allogeneic skin cells are effective in the treatment of chronic diabetic leg and foot ulcers.
Harvima IT; Virnes S; Kauppinen L; Huttunen M; Kivinen P; Niskanen L; Horsmanheimo M
Acta Derm Venereol; 1999 May; 79(3):217-20. PubMed ID: 10384921
[TBL] [Abstract][Full Text] [Related]
18. Delayed healing of chronic leg ulcers can result from impaired trafficking of bone marrow-derived precursors of keratinocytes to the skin.
Simka M
Med Hypotheses; 2007; 69(3):637-41. PubMed ID: 17337127
[TBL] [Abstract][Full Text] [Related]
19. Beta defensin-3 engineered epidermis shows highly protective effect for bacterial infection.
Sawamura D; Goto M; Shibaki A; Akiyama M; McMillan JR; Abiko Y; Shimizu H
Gene Ther; 2005 May; 12(10):857-61. PubMed ID: 15729370
[TBL] [Abstract][Full Text] [Related]
20. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
O'Meara S; Cullum N; Majid M; Sheldon T
Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
